Production (Stage)
Evoke Pharma, Inc.
EVOK
$2.89
-$0.0574-1.95%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -7.15% | 19.91% | 23.55% | -5.41% | 104.73% |
Total Receivables | 3.76% | 19.67% | 0.97% | 37.96% | 115.70% |
Inventory | 19.55% | -9.79% | -9.43% | -7.47% | 22.21% |
Prepaid Expenses | -28.42% | 398.91% | -61.69% | -45.63% | -20.43% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -10.71% | 20.60% | 31.41% | 339.68% | -86.74% |
Total Current Assets | -5.84% | 22.79% | 15.67% | -2.55% | 82.43% |
|
|||||
Total Current Assets | -5.84% | 22.79% | 15.67% | -2.55% | 82.43% |
Net Property, Plant & Equipment | -9.99% | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -95.04% | 9.87% | -- | -- | -- |
Total Assets | -6.52% | 23.78% | 16.62% | -2.55% | 76.19% |
|
|||||
Total Accounts Payable | 11.76% | 7.53% | -0.09% | 15.85% | 2.04% |
Total Accrued Expenses | -11.66% | 17.39% | 11.94% | 17.40% | -29.93% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 0.04% | 1.19% | 0.00% | 0.00% | 0.00% |
Total Finance Division Other Current Liabilities | 200.00% | -37.50% | 5.26% | -40.63% | 156.00% |
Total Other Current Liabilities | 200.00% | -37.50% | 5.26% | -40.63% | 156.00% |
Total Current Liabilities | 0.69% | 6.28% | 3.12% | 5.74% | -7.17% |
|
|||||
Total Current Liabilities | 0.69% | 6.28% | 3.12% | 5.74% | -7.17% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -17.62% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 0.51% | 7.32% | 3.12% | 5.74% | -7.17% |
|
|||||
Common Stock & APIC | 0.08% | 2.91% | 2.35% | 0.34% | 6.34% |
Retained Earnings | -1.01% | -0.93% | -1.04% | -1.01% | -1.28% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -17.00% | 60.42% | 64.62% | -23.80% | 235.58% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -17.00% | 60.42% | 64.62% | -23.80% | 235.58% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -17.00% | 60.42% | 64.62% | -23.80% | 235.58% |
|